← All trials
NCT06002659
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 1, 2023
- Primary completion
- Dec 30, 2027
- Completion date
- Dec 30, 2027
- First posted
- Aug 21, 2023
- Last posted
- Aug 21, 2023
- Enrollment
- 18
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Uppsala UniversityLead sponsor
- Karolinska InstituteCollaborator
- Uppsala UniversityStudy director
- Uppsala UniversityCollaborator
- Uppsala UniversityOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.